Literature DB >> 28432903

The decidua of preeclamptic-like BPH/5 mice exhibits an exaggerated inflammatory response during early pregnancy.

C Y Heyward1, J L Sones1, H E Lob1, L C Yuen1, K E Abbott1, W Huang2, Z R Begun1, S D Butler1, A August2, C A Leifer2, R L Davisson3.   

Abstract

Preeclampsia is a devastating complication of pregnancy characterized by late-gestation hypertension and proteinuria. Because the only definitive treatment is delivery of the fetus and placenta, preeclampsia contributes to increased morbidity and mortality of both mother and fetus. The BPH/5 mouse model, which spontaneously develops a syndrome strikingly similar to preeclampsia, displays excessive inflammation and suppression of inflammation improves pregnancy outcomes. During early pregnancy, decidual macrophages play an important role in promoting maternal tolerance to fetal antigens and regulating tissue remodeling, two functions that are critical for normal placental development. BPH/5 pregnancies are characterized by abnormal placentation; therefore, we hypothesized that macrophage localization and/or function is altered during early pregnancy at the site of placental formation (the decidua) compared to C57BL/6 controls. At early gestation time points, before the onset of maternal hypertension or proteinuria, there was a reduction in the number of macrophages in BPH/5 decidua and a concomitant increase in activated T cells compared with C57BL/6. BPH/5 decidua also exhibited decreased expression of the immunosuppressive cytokine, IL-10, and increased expression of pro-inflammatory, inducible nitric oxide synthase. Together, these data suggest that a reduction in decidual macrophages during pregnancy is associated with immune activation in BPH/5 mice, inadequate placental development and may contribute to adverse pregnancy outcomes in this model.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IL-10; Macrophages; T cells; Tolerance; iNOS

Mesh:

Substances:

Year:  2017        PMID: 28432903      PMCID: PMC5519141          DOI: 10.1016/j.jri.2017.04.002

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  43 in total

1.  Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice.

Authors:  Ashley K Woods; Darren S Hoffmann; Christine J Weydert; Scott D Butler; Yi Zhou; Ram V Sharma; Robin L Davisson
Journal:  Hypertension       Date:  2010-11-15       Impact factor: 10.190

Review 2.  The contribution of macrophages to normal and pathological pregnancies.

Authors:  Takeshi Nagamatsu; Danny J Schust
Journal:  Am J Reprod Immunol       Date:  2010-02-16       Impact factor: 3.886

3.  The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages.

Authors:  Judit Svensson-Arvelund; Ratnesh B Mehta; Robert Lindau; Elahe Mirrasekhian; Heriberto Rodriguez-Martinez; Göran Berg; Gendie E Lash; Maria C Jenmalm; Jan Ernerudh
Journal:  J Immunol       Date:  2015-01-05       Impact factor: 5.422

4.  The bacterial etiology of preterm birth.

Authors:  Kimberly K Jefferson
Journal:  Adv Appl Microbiol       Date:  2012       Impact factor: 5.086

Review 5.  A leading role for the immune system in the pathophysiology of preeclampsia.

Authors:  Estibalitz Laresgoiti-Servitje
Journal:  J Leukoc Biol       Date:  2013-04-30       Impact factor: 4.962

6.  Discovery of a spontaneous genetic mouse model of preeclampsia.

Authors:  Robin L Davisson; Darren S Hoffmann; Genelle M Butz; Gilbert Aldape; Gunther Schlager; David C Merrill; Sanjeev Sethi; Robert M Weiss; James N Bates
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

7.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.

Authors:  Nicola Gagliani; Chiara F Magnani; Samuel Huber; Monica E Gianolini; Mauro Pala; Paula Licona-Limon; Binggege Guo; De'Broski R Herbert; Alessandro Bulfone; Filippo Trentini; Clelia Di Serio; Rosa Bacchetta; Marco Andreani; Leonie Brockmann; Silvia Gregori; Richard A Flavell; Maria-Grazia Roncarolo
Journal:  Nat Med       Date:  2013-04-28       Impact factor: 53.440

8.  Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface.

Authors:  Patrice Nancy; Elisa Tagliani; Chin-Siean Tay; Patrik Asp; David E Levy; Adrian Erlebacher
Journal:  Science       Date:  2012-06-08       Impact factor: 47.728

9.  An M1-like Macrophage Polarization in Decidual Tissue during Spontaneous Preterm Labor That Is Attenuated by Rosiglitazone Treatment.

Authors:  Yi Xu; Roberto Romero; Derek Miller; Leena Kadam; Tara N Mial; Olesya Plazyo; Valeria Garcia-Flores; Sonia S Hassan; Zhonghui Xu; Adi L Tarca; Sascha Drewlo; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2016-02-17       Impact factor: 5.422

10.  Variation in NICU Admission Rates Without Identifiable Cause.

Authors:  Kathryn A Ziegler; David A Paul; Matthew Hoffman; Robert Locke
Journal:  Hosp Pediatr       Date:  2016-05
View more
  12 in total

1.  Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia.

Authors:  Jennifer L Sones; Audrey A Merriam; Angelina Seffens; Dex-Ann Brown-Grant; Scott D Butler; Anna M Zhao; Xinjing Xu; Carrie J Shawber; Jennifer K Grenier; Nataki C Douglas
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

2.  Three macrophage subsets are identified in the uterus during early human pregnancy.

Authors:  Xiangxiang Jiang; Mei-Rong Du; Min Li; Hongmei Wang
Journal:  Cell Mol Immunol       Date:  2018-04-04       Impact factor: 11.530

3.  Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia.

Authors:  Dorien Reijnders; Chin-Chi Liu; Xinjing Xu; Anna M Zhao; Kelsey N Olson; Scott D Butler; Nataki C Douglas; Jenny L Sones
Journal:  Physiol Genomics       Date:  2018-03-09       Impact factor: 3.107

4.  Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis: Systematic Review and Meta-Analysis.

Authors:  Meryl C Nath; Hajrunisa Cubro; Daniel J McCormick; Natasa M Milic; Vesna D Garovic
Journal:  Hypertension       Date:  2020-10-26       Impact factor: 10.190

Review 5.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

Review 6.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

Review 7.  Manipulating CD4+ T Cell Pathways to Prevent Preeclampsia.

Authors:  Eileen J Murray; Serena B Gumusoglu; Donna A Santillan; Mark K Santillan
Journal:  Front Bioeng Biotechnol       Date:  2022-01-12

8.  Genotypic analysis of the female BPH/5 mouse, a model of superimposed preeclampsia.

Authors:  Jenny L Sones; Christina C Yarborough; Valerie O'Besso; Alexander Lemenze; Nataki C Douglas
Journal:  PLoS One       Date:  2021-07-16       Impact factor: 3.240

Review 9.  Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond.

Authors:  Guillermina Girardi; Joshua J Lingo; Sherry D Fleming; Jean F Regal
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

10.  Potential regulatory network in the PSG10P/miR-19a-3p/IL1RAP pathway is possibly involved in preeclampsia pathogenesis.

Authors:  Nan Wang; Ruizhen Li; Min Xue
Journal:  J Cell Mol Med       Date:  2018-10-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.